IL17A and arthritic joint disease: In agreement with IL-17-dependence of IL1rn−/− arthritis [4, 8] and in line with our previous observations [12], GF IL1rn−/− mice showed a clear sustained protection from arthritis with on average 3 weeks delay in disease onset (Fig. 4e).